{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T02:48:56Z","timestamp":1775184536104,"version":"3.50.1"},"reference-count":21,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100004325","name":"AstraZeneca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011725","name":"Servier","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","onlinecjc.ca","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Canadian Journal of Cardiology"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1016\/j.cjca.2024.01.008","type":"journal-article","created":{"date-parts":[[2024,1,11]],"date-time":"2024-01-11T03:11:19Z","timestamp":1704942679000},"page":"1291-1293","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Restarting Anticoagulation After Major Bleeding in Patients With Atrial Fibrillation"],"prefix":"10.1016","volume":"40","author":[{"given":"Stephanie","family":"Carlin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4126-1285","authenticated-orcid":false,"given":"John","family":"Eikelboom","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cjca.2024.01.008_bib1","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1161\/01.STR.27.10.1760","article-title":"Stroke severity in atrial fibrillation. The Framingham Study","volume":"27","author":"Lin","year":"1996","journal-title":"Stroke"},{"key":"10.1016\/j.cjca.2024.01.008_bib2","doi-asserted-by":"crossref","first-page":"857","DOI":"10.7326\/0003-4819-146-12-200706190-00007","article-title":"Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation","volume":"146","author":"Hart","year":"2007","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.cjca.2024.01.008_bib3","article-title":"Oral anticoagulants for preventing stroke in patients with nonvalvular atrial fibrillation and no previous history of stroke or transient ischemic attacks","volume":"2005","author":"Aguilar","year":"2005","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.cjca.2024.01.008_bib4","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1161\/CIRCULATIONAHA.118.036248","article-title":"Major bleeding rates in atrial fibrillation patients on single, dual, or triple antithrombotic therapy","volume":"139","author":"van Rein","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2024.01.008_bib5","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1056\/NEJMoa1707278","article-title":"Idarucizumab for dabigatran reversal\u2014full cohort analysis","volume":"377","author":"Pollack","year":"2017","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cjca.2024.01.008_bib6","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1161\/CIRCULATIONAHA.121.057844","article-title":"Final study report of andexanet\u00a0alfa for major bleeding with factor Xa inhibitors","volume":"147","author":"Milling","year":"2023","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2024.01.008_bib7","first-page":"3126","article-title":"Meta-analysis of haematoma volume, haematoma expansion and mortality in intracerebral haemorrhage associated with oral anticoagulant use","volume":"266","author":"Seiffge","year":"2019","journal-title":"J\u00a0Neurol"},{"key":"10.1016\/j.cjca.2024.01.008_bib8","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/j.jacc.2020.04.053","article-title":"2020 ACC expert consensus decision pathway on management of bleeding in patients on oral anticoagulants: a report of the American College of Cardiology Solution Set Oversight Committee","volume":"76","author":"Tomaselli","year":"2020","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.cjca.2024.01.008_bib9","doi-asserted-by":"crossref","first-page":"e282","DOI":"10.1161\/STR.0000000000000407","article-title":"2022 guideline for the management of patients with spontaneous intracerebral hemorrhage: a guideline from the American Heart Association\/American Stroke Association","volume":"53","author":"Greenberg","year":"2022","journal-title":"Stroke"},{"key":"10.1016\/j.cjca.2024.01.008_bib10","first-page":"1283","article-title":"Real-world management strategies of anticoagulated atrial fibrillation patients after a clinically significant bleeding episode","volume":"40","author":"Brouillard","year":"2024","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.cjca.2024.01.008_bib11","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.thromres.2019.01.020","article-title":"Resumption of anticoagulant therapy after anticoagulant-related gastrointestinal bleeding: a systematic review and meta-analysis","volume":"175","author":"Little","year":"2019","journal-title":"Thromb Res"},{"key":"10.1016\/j.cjca.2024.01.008_bib12","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.ijcard.2018.03.053","article-title":"Restarting oral anticoagulant therapy after major bleeding in atrial fibrillation: a systematic review and meta-analysis","volume":"261","author":"Proietti","year":"2018","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.cjca.2024.01.008_bib13","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1007\/s10620-020-06248-9","article-title":"Resuming anticoagulation following hospitalization for gastrointestinal bleeding is associated with reduced thromboembolic events and improved mortality: results from a systematic review and meta-analysis","volume":"66","author":"Tapaskar","year":"2021","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.cjca.2024.01.008_bib14","doi-asserted-by":"crossref","first-page":"2618","DOI":"10.1111\/jth.15476","article-title":"Recurrent bleeding and thrombotic events after resumption of oral anticoagulants following gastrointestinal bleeding: communication from the ISTH SSC Subcommittee on Control of Anticoagulation","volume":"19","author":"Candeloro","year":"2021","journal-title":"J\u00a0Thromb Haemost"},{"issue":"10411","key":"10.1016\/j.cjca.2024.01.008_bib15","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1016\/S0140-6736(23)02025-1","article-title":"Anticoagulation in patients with cerebral amyloid angiopathy","volume":"402","author":"Shoamanesh","year":"2023","journal-title":"Lancet"},{"key":"10.1016\/j.cjca.2024.01.008_bib16","article-title":"Two-year outcomes with a next-generation left atrial appendage device: final results of the PINNACLE FLX trial","volume":"12","author":"Doshi","year":"2023","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.cjca.2024.01.008_bib17","doi-asserted-by":"crossref","first-page":"3122","DOI":"10.1016\/j.jacc.2020.04.067","article-title":"Left atrial appendage closure versus direct oral anticoagulants in high-risk patients with atrial fibrillation","volume":"75","author":"Osmancik","year":"2020","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.cjca.2024.01.008_bib18","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1056\/NEJMoa1107039","article-title":"Apixaban versus warfarin in patients with atrial fibrillation","volume":"365","author":"Granger","year":"2011","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cjca.2024.01.008_bib19","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.arr.2018.10.006","article-title":"Overview of oral antithrombotic treatment in elderly patients with atrial fibrillation","volume":"49","author":"Kato","year":"2019","journal-title":"Ageing Res Rev"},{"key":"10.1016\/j.cjca.2024.01.008_bib20","doi-asserted-by":"crossref","first-page":"382","DOI":"10.7326\/M15-0143","volume":"163","author":"Gladstone","year":"2015","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.cjca.2024.01.008_bib21","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1016\/S1474-4422(23)00315-0","article-title":"Effects of oral anticoagulation in people with atrial fibrillation after spontaneous intracranial haemorrhage (COCROACH): prospective, individual participant data meta-analysis of randomised trials","volume":"22","author":"Al-Shahi Salman","year":"2023","journal-title":"Lancet Neurol"}],"container-title":["Canadian Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0828282X24000199?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0828282X24000199?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T01:50:38Z","timestamp":1775181038000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0828282X24000199"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":21,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2024,7]]}},"alternative-id":["S0828282X24000199"],"URL":"https:\/\/doi.org\/10.1016\/j.cjca.2024.01.008","relation":{},"ISSN":["0828-282X"],"issn-type":[{"value":"0828-282X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Restarting Anticoagulation After Major Bleeding in Patients With Atrial Fibrillation","name":"articletitle","label":"Article Title"},{"value":"Canadian Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cjca.2024.01.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.cjca.2023.12.032","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Canadian Cardiovascular Society. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}